{"id":62980,"date":"2026-06-11T01:38:18","date_gmt":"2026-06-11T05:38:18","guid":{"rendered":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/global-market-update-china-tightens-grip-on-ai-supply-chain-while-hong-kong-reclaims-tech-listing-crown\/62980\/"},"modified":"2026-06-11T01:38:18","modified_gmt":"2026-06-11T05:38:18","slug":"global-market-update-china-tightens-grip-on-ai-supply-chain-while-hong-kong-reclaims-tech-listing-crown","status":"publish","type":"post","link":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/global-market-update-china-tightens-grip-on-ai-supply-chain-while-hong-kong-reclaims-tech-listing-crown\/62980\/","title":{"rendered":"Global Market Update: China Tightens Grip on AI Supply Chain While Hong Kong Reclaims Tech Listing Crown"},"content":{"rendered":"<h2>Key Takeaways<\/h2>\n<ul>\n<li><strong>China\u2019s Indium Phosphide (InP) export controls<\/strong> are creating a critical bottleneck for U.S. photonic chip manufacturers, threatening the global rollout of <strong>AI data centers<\/strong>.<\/li>\n<li><strong>Hong Kong Exchanges and Clearing (HKEX)<\/strong> reports a sevenfold surge in tech share transaction volumes over the last decade, cementing the city&#39;s status as a premier global listing hub.<\/li>\n<li><strong>Roche (<a href=\"\/stock\/RHHBY\">RHHBY<\/a>)<\/strong> received <strong>FDA Priority Review<\/strong> for Tecentriq in stage III colon cancer, showing a <strong>50% reduction<\/strong> in recurrence risk.<\/li>\n<li><strong>Novartis (<a href=\"\/stock\/NVS\">NVS<\/a>)<\/strong> advanced its FSHD candidate, <strong>del-brx<\/strong>, into Phase III with FDA Fast Track status following successful trial endpoints.<\/li>\n<li><strong>Japan\u2019s 40-year government bond yield<\/strong> climbed to <strong>3.765%<\/strong>, reflecting continued upward pressure on long-term borrowing costs.<\/li>\n<\/ul>\n<hr>\n<h2>Semiconductor Supply Chain: China\u2019s InP Leverage<\/h2>\n<p>U.S. officials have engaged in multiple rounds of talks with Chinese authorities to resolve ongoing delays in <strong>Indium Phosphide (InP)<\/strong> export approvals. Despite these efforts, Beijing continues to stall shipments, causing significant disruptions for U.S. photonic chip manufacturers who rely on the material for high-speed optical interconnects in <strong>AI infrastructure<\/strong>.<\/p>\n<p>Chinese domestic producers, including <strong>Yunnan Germanium<\/strong> and <strong>Guangdong Xiandao<\/strong>, are reportedly prioritizing the domestic market to maintain China&#39;s strategic advantage. While these companies are seeking export licenses, analysts expect overseas shipments to remain severely restricted for the foreseeable future, potentially capping the expansion speed of global AI clusters.<\/p>\n<h2>Capital Markets: Hong Kong\u2019s Tech Resurgence<\/h2>\n<p>Hong Kong has officially emerged as the top listing hub for global technology firms, according to the <strong>Hong Kong Exchanges and Clearing (<a href=\"\/stock\/HKXCF\">HKEX<\/a>)<\/strong>. CEO Bonnie Chan highlighted that the city\u2019s capital markets have seen a structural shift toward emerging industries, with tech sector trading volumes growing by <strong>700%<\/strong> over the last ten years.<\/p>\n<p>The exchange\u2019s momentum is supported by a robust IPO pipeline, with over <strong>HK$166 billion ($21.2 billion)<\/strong> raised in the first five months of 2026. This resurgence is driven by a pivot toward premium AI and biotech sectors, positioning Hong Kong as a vital bridge between Asian innovation and global capital.<\/p>\n<h2>Healthcare: Breakthroughs in Oncology and Rare Diseases<\/h2>\n<p><strong>Roche (<a href=\"\/stock\/RHHBY\">RHHBY<\/a>)<\/strong> announced that the FDA has granted <strong>Priority Review<\/strong> for its immunotherapy <strong>Tecentriq<\/strong> as an adjuvant treatment for specific stage III colon cancers. Data from the Phase III ATOMIC study demonstrated a <strong>36-month disease-free survival (DFS) rate of 86%<\/strong>, significantly outperforming the 76% achieved by standard chemotherapy alone.<\/p>\n<p>Simultaneously, <strong>Novartis (<a href=\"\/stock\/NVS\">NVS<\/a>)<\/strong> is moving forward with <strong>del-brx<\/strong> (delpacibart braxlosiran) for facioscapulohumeral muscular dystrophy (FSHD). The drug has met key clinical endpoints and is currently in <strong>Phase III trials<\/strong> with both <strong>Orphan Drug<\/strong> and <strong>Fast Track<\/strong> designations from the FDA, targeting a disease with no currently approved therapies.<\/p>\n<h2>Defense and Macro: Rheinmetall Orders and Rising Yields<\/h2>\n<p><strong>Rheinmetall (<a href=\"\/stock\/RNMBF\">RHM<\/a>)<\/strong> has secured a significant contract from the Danish Ministry of Defence to supply five <strong>Role 2 field hospitals<\/strong>. The order, valued in the mid double-digit million-euro range, includes both mobile containerized units and enhanced diagnostic facilities, with deliveries expected to be completed within two years.<\/p>\n<p>In the fixed-income markets, the <strong>40-year Japanese Government Bond (JGB) yield<\/strong> advanced by 3.0 basis points to reach <strong>3.765%<\/strong>. This move underscores the broader trend of rising long-term rates in Japan as investors recalibrate expectations for monetary policy and fiscal sustainability.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key Takeaways China\u2019s Indium Phosphide (InP) export controls are creating a critical bottleneck for U.S. photonic chip manufacturers, threatening the [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":50383,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"rank_math_schema_Article":[],"rank_math_focus_keyword":[],"rank_math_description":[],"financial_data_references":[],"stock_symbols_mentioned":[],"footnotes":""},"categories":[5012],"tags":[5777,1327,6225,1466,6254,1938,7777,2603,11603,3703,13474,5027,5112,5383,5664],"class_list":["post-62980","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breaking-news","tag-novartis","tag-china","tag-hong-kong","tag-nvs","tag-roche","tag-rhhby","tag-rhm","tag-dfs","tag-hkex","tag-ai","tag-fshd","tag-semiconductors","tag-jgb","tag-biotech","tag-rheinmetall"],"_links":{"self":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/62980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/comments?post=62980"}],"version-history":[{"count":0,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/posts\/62980\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media\/50383"}],"wp:attachment":[{"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/media?parent=62980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/categories?post=62980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www2.stockmarketwatch.com\/stock-market-news\/wp-json\/wp\/v2\/tags?post=62980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}